BRINGING REJUVENATION BIOTECHNOLOGY AND INVESTORS TOGETHER

At the Frederick P. Rose Auditorium, Cooper Union in New York City, we will be hosting a special one-day conference focused on aging research and biotech investment. Developing therapies from initial concepts, through clinical testing, and ultimately to market takes a pipeline, and right now, that pipeline is being built to support the next step in medicine: rejuvenation biotechnology. Join us for this exciting event, where industry experts will be sharing their insights on the advances and investment prospects in an industry poised to revolutionize medicine forever.

OFFICIAL EVENT SPONSORS

INDUSTRY EXPERTS FROM RESEARCH AND INVESTMENT

We bring you insights from the leading experts in research and biotech investment, who will guide you through the industry in a series of talks and presentations. Below are the confirmed guests, and we will be announcing more speakers soon, so be sure to check back with us often to see who else will be joining us.

Dr. Aubrey de Grey

SENS Research Foundation

Dr. Oliver Medvedik

Kanbar Center for Biomedical Engineering

Dr. Vadim Gladyshev

Harvard medical school, USA

Bobby Brooke

Intervene Immune

Dr. Mark Hammond

Deep Science Ventures

Dr. Sudhir Paul

Covalent Bioscience

Dr. Vera Gorbunova

University of Rochester

Steven A. Garan

University of California, Berkeley & Lawrence Berkeley National Laboratory

Stephen Hilbert

Oisin Biotechnologies

Dr. Alvaro Macieira-Coelho

French Institute of Health and Medical Research - Inserm

Reason

Fight Aging & Repair Biotechnologies

Dr. Michael West

AgeX Therapeutics and Co-CEO, BioTime

Kelsey Moody

Ichor Therapeutics

Dr. Antonei Csoka

Howard University

EVENT PROGRAM

We have a feature-packed event program planned for you to enjoy, and it will include an overview of progress in the field, prospects for translational research, venture philanthropy, policy and regulation insights, and the challenges that the industry faces.